Atlas Trials

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

Clinical trial NCT05049733 · COMPLETED

Trial details

NCT number
NCT05049733
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cannabis
Start date
2022-03-07
Primary completion
2023-06-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.